Investment manager Arkin Capital has closed a $100 million financing round to set up Arkin Bio Ventures III, a $100m fund aimed at investing in biotech companies.  Arkin Bio Ventures III will back 10 to 12 pre-clinical to early clinical-stage biotech companies, developing transformative therapies in areas of high unmet medical needs.  The latest venture […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!